PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

BACKGROUND: Human papillomavirus-positive oropharyngeal squamous cell carcinoma is increasing in incidence worldwide. Current treatments are associated with high survival rates but often result in significant long-term toxicities. In particular, long-term dysphagia has a negative impact on patient q...

Descripción completa

Detalles Bibliográficos
Autores principales: Owadally, Waheeda, Hurt, Chris, Timmins, Hayley, Parsons, Emma, Townsend, Sarah, Patterson, Joanne, Hutcheson, Katherine, Powell, Ned, Beasley, Matthew, Palaniappan, Nachi, Robinson, Max, Jones, Terence M., Evans, Mererid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549836/
https://www.ncbi.nlm.nih.gov/pubmed/26311526
http://dx.doi.org/10.1186/s12885-015-1598-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549836/
https://www.ncbi.nlm.nih.gov/pubmed/26311526
http://dx.doi.org/10.1186/s12885-015-1598-x

Ejemplares similares